Concord Biotech Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Mar '25
Dec '24
Sep '24
Jun '24
Mar '24
Total Qtr Revenue cr
439.27
258.95
320.21
226.11
329.78
Other Income Qtr Cr9.3814.7310.0310.3110.81
Operating Revenues Qtr429.88244.22310.18215.80318.97

*All values are in Cr.

Operating Expenses Qtr
239.46
146.27
173.50
134.52
184.68
Operating Profit Qtr
190.42
97.95
136.68
81.28
134.29
EBITDA Qtr Cr
199.81
112.68
146.70
91.59
145.10
Depreciation Qtr
14.62
13.26
13.31
13.18
13.72
Net Profit Qtr
140.39
75.92
95.74
59.59
95.02
Basic EPS Qtr
13.42
7.26
9.15
5.70
9.08
Open Demat Account
+91 -

Open Demat Account
+91 -